array:23 [
  "pii" => "S2174204914002736"
  "issn" => "21742049"
  "doi" => "10.1016/j.repce.2014.09.007"
  "estado" => "S300"
  "fechaPublicacion" => "2014-11-01"
  "aid" => "535"
  "copyright" => "Sociedade Portuguesa de Cardiologia"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "prv"
  "cita" => "Rev Port Cardiol. 2014;33:751-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2676
    "formatos" => array:3 [
      "EPUB" => 134
      "HTML" => 1897
      "PDF" => 645
    ]
  ]
  "Traduccion" => array:1 [
    "pt" => array:19 [
      "pii" => "S0870255114002339"
      "issn" => "08702551"
      "doi" => "10.1016/j.repc.2014.09.005"
      "estado" => "S300"
      "fechaPublicacion" => "2014-11-01"
      "aid" => "535"
      "copyright" => "Sociedade Portuguesa de Cardiologia"
      "documento" => "simple-article"
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "prv"
      "cita" => "Rev Port Cardiol. 2014;33:751-2"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2795
        "formatos" => array:3 [
          "EPUB" => 181
          "HTML" => 1909
          "PDF" => 705
        ]
      ]
      "pt" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Artigo recomendado do m&#234;s</span>"
        "titulo" => "Coment&#225;rio a &#171;Interven&#231;&#227;o coron&#225;ria percut&#226;nea com pr&#243;teses vasculares bioabsorv&#237;veis eluidoras de <span class="elsevierStyleItalic">everolimus</span> na pr&#225;tica cl&#237;nica de rotina&#58; resultados precoces e a m&#233;dio prazo do Registo Europeu Multic&#234;ntrico GOST&#8208;EU&#187;"
        "tienePdf" => "pt"
        "tieneTextoCompleto" => "pt"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "751"
            "paginaFinal" => "752"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Comment on &#8220;Percutaneous coronary intervention with everolimus&#8208;eluting bioabsorbable vascular scaffolds in routine clinical practice&#58; early and midterm outcomes from the European multicentre GHOST&#8208;EU registry&#8221;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "pt" => true
        ]
        "contienePdf" => array:1 [
          "pt" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Henrique Cyrne Carvalho"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Henrique"
                "apellidos" => "Cyrne Carvalho"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "pt"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2174204914002736"
          "doi" => "10.1016/j.repce.2014.09.007"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002736?idApp=UINPBA00004E"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114002339?idApp=UINPBA00004E"
      "url" => "/08702551/0000003300000011/v1_201411200056/S0870255114002339/v1_201411200056/pt/main.assets"
    ]
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2174204914002724"
    "issn" => "21742049"
    "doi" => "10.1016/j.repce.2014.05.009"
    "estado" => "S300"
    "fechaPublicacion" => "2014-11-01"
    "aid" => "549"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "article"
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Rev Port Cardiol. 2014;33:747-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2340
      "formatos" => array:3 [
        "EPUB" => 157
        "HTML" => 1675
        "PDF" => 508
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Image in Cardiology</span>"
      "titulo" => "Collateral damage from a coronary blush"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "747"
          "paginaFinal" => "749"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Danos colaterais com <span class="elsevierStyleItalic">blush</span> coron&#225;rio"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 3480
              "Ancho" => 2334
              "Tamanyo" => 688212
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;a&#8211;c&#41; Three-dimensional volume rendered cardiac computed tomography images showing the relationship of the coronary artery fistula &#40;arrow&#41; to the right ventricular outflow tract&#44; aorta and main pulmonary artery in anterior &#40;a&#41;&#44; anterolateral &#40;b&#41; and lateral &#40;c&#41; planes&#59; &#40;d&#41; curved multiplanar reformatted cardiac computed tomographic image showing the course of the coronary artery fistula anterior to the right ventricular outflow tract&#59; &#40;e&#41; multiplanar reformatted cardiac computed tomographic image showing the presence of a non-calcified bicuspid aortic valve&#59; &#40;f&#41; curved multiplanar reformatted cardiac computed tomographic image showing the presence of a concomitant aortopathy&#46; Ao&#58; aorta&#59; LAD&#58; left anterior descending coronary artery&#59; LV&#58; left ventricle&#59; MPA&#58; main pulmonary artery&#59; RVOT&#58; right ventricular outflow tract&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Panagiotis Koudounis, Jessica Webb, Camila Cabral, Natali Chung, Ronak Rajani"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Panagiotis"
              "apellidos" => "Koudounis"
            ]
            1 => array:2 [
              "nombre" => "Jessica"
              "apellidos" => "Webb"
            ]
            2 => array:2 [
              "nombre" => "Camila"
              "apellidos" => "Cabral"
            ]
            3 => array:2 [
              "nombre" => "Natali"
              "apellidos" => "Chung"
            ]
            4 => array:2 [
              "nombre" => "Ronak"
              "apellidos" => "Rajani"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0870255114002649"
        "doi" => "10.1016/j.repc.2014.05.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114002649?idApp=UINPBA00004E"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002724?idApp=UINPBA00004E"
    "url" => "/21742049/0000003300000011/v1_201412120159/S2174204914002724/v1_201412120159/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Recommended article of the Month</span>"
    "titulo" => "Comment on &#8220;Percutaneous coronary intervention with everolimus-eluting bioabsorbable vascular scaffolds in routine clinical practice&#58; early and midterm outcomes from the European multicentre GHOST-EU registry&#8221;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "751"
        "paginaFinal" => "752"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Henrique Cyrne Carvalho"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "Henrique"
            "apellidos" => "Cyrne Carvalho"
            "email" => array:1 [
              0 => "henriquecyrnecarvalho&#64;hotmail&#46;com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Membro do Corpo Redatorial da Revista&#44; Portuguesa de Cardiologia"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Coment&#225;rio a &#171;Interven&#231;&#227;o coron&#225;ria percut&#226;nea com pr&#243;teses vasculares bioabsorv&#237;veis eluidoras de <span class="elsevierStyleItalic">everolimus</span> na pr&#225;tica cl&#237;nica de rotina&#58; resultados precoces e a m&#233;dio prazo do Registo Europeu Multic&#234;ntrico GOST-EU&#187;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="tb0005"></elsevierMultimedia></p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Abstract</span><p id="par0015" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Aims&#58;</span> Clinical data on the early and midterm outcomes of bioresorbable vascular scaffolds &#40;BVS&#41; in routine clinical practice are limited&#46; To fill this gap&#44; we report on the early and midterm clinical outcomes of PCI with everolimus-eluting BVS from the large multicentre GHOST-EU registry&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Methods and results&#58;</span> Between November 2011 and January 2014&#44; 1&#44;189 patients underwent percutaneous coronary intervention with one or more BVS &#40;Absorb BVS&#59; Abbott Vascular&#44; Santa Clara&#44; CA&#44; USA&#41; at 10 European centres&#46; The primary outcome of interest was target lesion failure &#40;TLF&#41;&#44; defined as the combination of cardiac death&#44; target vessel myocardial infarction&#44; or clinically driven target lesion revascularisation &#40;TLR&#41;&#46; A total of 1&#44;731 Absorb BVS were implanted at a mean of 12&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;4 atm&#46; Technical success was achieved in 99&#46;7&#37; of cases&#46; TLF was recorded in 67 of 1&#44;189 patients at a median of 109 &#40;interquartile range 8-227&#41; days after implantation&#46; The cumulative incidence of TLF was 2&#46;2&#37; at 30 days and 4&#46;4&#37; at six months&#46; The annualised rate of TLF was 10&#46;1&#37;&#46; At six months&#44; the rate of cardiac death was 1&#46;0&#37;&#44; target vessel myocardial infarction was 2&#46;0&#37;&#44; TLR was 2&#46;5&#37;&#44; and target vessel revascularisation was 4&#46;0&#37;&#46; Diabetes mellitus was the only independent predictor of TLF &#40;hazard ratio 2&#46;41&#44; 95&#37; confidence interval&#58; 1&#46;28-4&#46;53&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;006&#41;&#46; The cumulative incidence of definite&#47;probable scaffold thrombosis was 1&#46;5&#37; at 30 days and 2&#46;1&#37; at six months&#44; with 16 of 23 cases occurring within 30 days&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Conclusions&#58;</span> &#8220;Real-world&#8221; outcomes of BVS showed acceptable rates of TLF at six months&#44; although the rates of early and midterm scaffold thrombosis&#44; mostly clustered within 30 days&#44; were not negligible&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Comment</span><p id="par0020" class="elsevierStylePara elsevierViewall">A r&#225;pida evolu&#231;&#227;o relativa &#224; interven&#231;&#227;o coron&#225;ria percut&#226;nea processou-se de acordo com inova&#231;&#245;es que progressivamente vieram a garantir maior efic&#225;cia e&#44; indiscutivelmente&#44; maior seguran&#231;a&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Ap&#243;s a angioplastia por bal&#227;o&#44; primeira grande revolu&#231;&#227;o e evolu&#231;&#227;o no tratamento da doen&#231;a card&#237;aca isqu&#233;mica&#44; houve necessidade de encontrar solu&#231;&#227;o para o tratamento r&#225;pido e eficaz da disse&#231;&#227;o condicionante do fluxo que resultava do barotrauma induzido pelo bal&#227;o&#46; Nesse contexto surgem os <span class="elsevierStyleItalic">stents</span> autoexpans&#237;veis e&#44; posteriormente&#44; os <span class="elsevierStyleItalic">stents</span> expans&#237;veis por bal&#227;o&#46; Esta foi a segunda grande revolu&#231;&#227;o na cardiologia de interven&#231;&#227;o para o tratamento da doen&#231;a coron&#225;ria&#46; Al&#233;m de resolverem as condi&#231;&#245;es de interrup&#231;&#227;o aguda do fluxo j&#225; referidas&#44; estas pr&#243;teses mostram diminuir o processo de reestenose quando comparada com a angioplastia por bal&#227;o&#46; Este facto permitiu que les&#245;es de complexidade anat&#243;mica crescente fossem tratadas&#44; resultando deste facto um novo acr&#233;scimo cumulativo do processo de reestenose&#46; Era por isso necess&#225;rio encontrar solu&#231;&#245;es que procurassem resolver este problema de import&#226;ncia crescente&#44; determinado pelo enorme n&#250;mero de les&#245;es que passaram a ser tratadas em cada doente&#46; &#201; neste ambiente que surgem os <span class="elsevierStyleItalic">stents</span> met&#225;licos eluidores de subst&#226;ncias antiproliferativas&#44; que tinham como objetivo controlar o processo proliferativo que determinava o fen&#243;meno de reestenose&#46; Estes <span class="elsevierStyleItalic">stents</span>&#44; constitu&#237;dos por tr&#234;s elementos &#8211; plataforma met&#225;lica&#44; pol&#237;mero&#44; onde s&#227;o elu&#237;dos os f&#225;rmacos antiproliferativos&#44; e f&#225;rmaco antiproliferativo &#8211; constitu&#237;ram a terceira grande revolu&#231;&#227;o na cardiologia de interven&#231;&#227;o no tratamento da doen&#231;a card&#237;aca isqu&#233;mica&#46; Era a partir desse momento poss&#237;vel tratar maior n&#250;mero de doentes com grande efic&#225;cia&#44; permitindo que muitos dos doentes anteriormente candidatos a cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica pudessem ser tratados de forma adequada por interven&#231;&#227;o percut&#226;nea&#46; No entanto&#44; a efic&#225;cia associada &#224; antiprolifera&#231;&#227;o determinava tempos de reendoteliza&#231;&#227;o mais prolongados&#44; o que por si condicionava a necessidade de uma terap&#234;utica antiagregante tamb&#233;m mais prolongada para evitar o processo de trombose dependente do tempo mais longo da exposi&#231;&#227;o da malha met&#225;lica &#224; corrente sangu&#237;nea&#46; O pr&#243;prio pol&#237;mero&#44; necess&#225;rio &#224; elui&#231;&#227;o do f&#225;rmaco antiproliferativo&#44; tamb&#233;m se viria a demonstrar estar associado ao processo inflamat&#243;rio que conduzia ao atraso na reendoteliza&#231;&#227;o do <span class="elsevierStyleItalic">stent</span>&#46; O passo seguinte foi o de utilizar pol&#237;meros bioabsorv&#237;veis que diminu&#237;ssem o processo a que anteriormente nos referimos&#46; No entanto&#44; persistia um problema&#58; estavam a ser implantadas pr&#243;teses definitivas para tratar um processo que por si s&#243; era tempor&#225;rio&#44; determinando condi&#231;&#245;es fisiopatol&#243;gicas que condicionavam novos processos e novas &#171;doen&#231;as&#187;&#58; os processos de reestenose e de trombose da pr&#243;tese intracoron&#225;ria&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">&#201; neste ambiente que surge a quarta revolu&#231;&#227;o no tratamento da doen&#231;a card&#237;aca isqu&#233;mica por via percut&#226;nea&#58; o desenvolvimento de pr&#243;teses intracoron&#225;rias eluidoras de f&#225;rmacos com pol&#237;mero e plataforma completamente bioabsorv&#237;veis<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Da informa&#231;&#227;o cient&#237;fica j&#225; dispon&#237;vel relativamente a estas pr&#243;teses e&#44; particularmente a da ABBOTT VASCULAR &#40;ABSORB BVS&#44; constitu&#237;da por um pol&#237;mero bioabsorv&#237;vel&#41; que &#233; a que j&#225; apresenta mais evid&#234;ncia cient&#237;fica&#44; ressaltam dois elementos base&#58; s&#227;o pr&#243;teses eficazes e associadas a baixa taxa de complica&#231;&#245;es tromb&#243;ticas&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Ap&#243;s uma primeira fase em que foram testadas no modelo animal com enorme sucesso&#44; passou-se para a sua utiliza&#231;&#227;o em humanos&#44; com les&#245;es de baixa complexidade anat&#243;mica&#46; Est&#227;o neste momento a decorrer estudos de larga escala&#44; procurando encontrar esses mesmos resultados na popula&#231;&#227;o em geral e em subgrupos de doentes associados a perfis de maior complexidade anat&#243;mica e cl&#237;nica&#46; At&#233; este ponto&#44; esses resultados t&#234;m sido encorajadores&#46; O conceito de que estas pr&#243;teses n&#227;o sirvam apenas como um elemento de conten&#231;&#227;o da placa &#8211; <span class="elsevierStyleItalic">scaffolding</span> &#8211;&#44; mas possam tamb&#233;m ser um elemento de regenera&#231;&#227;o funcional da placa e da fisiologia normal do segmento arterial coron&#225;rio&#44; est&#225; progressivamente a ganhar consist&#234;ncia&#46; Por outro lado&#44; tem sido observado em estudos morfol&#243;gicos intracoron&#225;rios&#44; que a cicatriza&#231;&#227;o ap&#243;s absor&#231;&#227;o completa da pr&#243;tese se fa&#231;a&#44; ao contr&#225;rio do que acontece com os <span class="elsevierStyleItalic">stents</span> met&#225;licos&#44; com alargamento luminal e alargamento da &#225;rea do segmento tratado<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#8211;5</span></a>&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">O Registo em an&#225;lise procura a informa&#231;&#227;o relativa &#224; utiliza&#231;&#227;o destas pr&#243;teses tempor&#225;rias em condi&#231;&#245;es de tratamento de doentes do &#171;mundo real&#187;&#44; em ambiente diferente do utilizado nos estudos que permitiram a sua certifica&#231;&#227;o&#46; Dos resultados desta avalia&#231;&#227;o que envolveu mais de 1000 doentes&#44; o maior registo publicado sobre estas pr&#243;teses&#44; destacam-se duas conclus&#245;es essenciais&#58; o BVS apresenta taxas aceit&#225;veis de TLF aos seis meses e taxas n&#227;o desprez&#237;veis de trombose&#44; que ocorre sobretudo nos primeiros 30 dias&#44; e se aproximam das identificadas nos DES de primeira gera&#231;&#227;o&#46; Apesar de n&#227;o serem n&#250;meros alarmantes&#44; n&#227;o s&#227;o negligenci&#225;veis e podem justificar algum cuidado na utiliza&#231;&#227;o de BVS em popula&#231;&#245;es n&#227;o selecionadas&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Este registo identifica tamb&#233;m os fatores preditivos de <span class="elsevierStyleItalic">target lesion failure</span> &#40;TLF&#41; e investiga o impacto da curva de aprendizagem no resultado cl&#237;nico&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Ser&#225; interessante avaliar o comportamento desta popula&#231;&#227;o ao fim de tempos de <span class="elsevierStyleItalic">follow-up</span> mais prolongados&#46; Teremos que aguardar por esses resultados e continuar a ser criteriosos na sele&#231;&#227;o dos doentes e exigentes tecnicamente na sua utiliza&#231;&#227;o&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:3 [
        0 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Abstract"
        ]
        1 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Comment"
        ]
        2 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:5 [
        "identificador" => "tb0005"
        "tipo" => "MULTIMEDIATEXTO"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "texto" => array:1 [
          "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0010" class="elsevierStylePara elsevierViewall">Percutaneous coronary intervention with everolimus-eluting bioabsorbable vascular scaffolds in routine clinical practice&#58; early and midterm outcomes from the European multicentre GHOST-EU registry&#46; Davide Capodanno&#44; Tommaso Gori&#44; Holger Nef&#44; Azeem Latib&#44; Julinda Mehilli&#44; Maciej Lesiak&#44; Giuseppe Caramanno&#44; Christoph Naber&#44; Carlo Di Mario&#44; Antonio Colombo&#44; Piera Capranzano&#44; Jens Wiebe&#44; Aleksander Araszkiewicz&#44; Salvatore Geraci&#44; Stelios Pyxaras&#44; Alessio Mattesini&#44; Toru Naganuma&#44; Thomas M&#252;nzel&#44; Corrado Tamburino&#46; EuroIntervention 2014&#59;10-online publish-ahead-of-print July 2014&#46; doi&#58; 10&#46;4244&#47;EIJY14M07&#95;11</p></span>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system&#58; multimodality imaging assessment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "H&#46;M&#46; Garc&#237;a-Garc&#237;a"
                            1 => "C&#46; Schultz"
                            2 => "E&#46; Duckers"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4244/EIJV8I10A175"
                      "Revista" => array:6 [
                        "tituloSerie" => "EuroIntervention&#46;"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "1126"
                        "paginaFinal" => "1127"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23425538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46; Diletti"
                            1 => "V&#46; Farooq"
                            2 => "C&#46; Girasis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Late lumen enlargement&#58; does bioresorption matter with small vessel size&#63; Insight from the ABSORB cohort B trial&#46; Heart&#46;"
                        "fecha" => "2013"
                        "volumen" => "99"
                        "paginaInicial" => "98"
                        "paginaFinal" => "105"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "ABSORB II randomized controlled trial&#58; a clinical evaluation to compare the safety&#44; efficacy&#44; and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions&#58; rationale and study design"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46; Diletti"
                            1 => "P&#46;W&#46; Serruys"
                            2 => "V&#46; Farooq"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ahj.2012.08.010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am Heart J&#46;"
                        "fecha" => "2012"
                        "volumen" => "164"
                        "paginaInicial" => "654"
                        "paginaFinal" => "663"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23137495"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "ABSORB-EXTEND Investigators&#46; Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold&#46; an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46; Muramatsu"
                            1 => "Y&#46; Onuma"
                            2 => "H&#46;M&#46; Garc&#237;a-Garc&#237;a"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcin.2012.10.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "JACC Cardiovasc Interv&#46;"
                        "fecha" => "2013"
                        "volumen" => "6"
                        "paginaInicial" => "247"
                        "paginaFinal" => "257"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23517836"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Posi&#231;&#227;o sobre suportes vasculares restaurativos transit&#243;rios coron&#225;rios em Portugal"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46; Campante Teles"
                            1 => "H&#46; Pereira"
                            2 => "H&#46; Cyrne de Carvalho"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.repc.2013.05.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Port Cardiol&#46;"
                        "fecha" => "2013"
                        "volumen" => "32"
                        "paginaInicial" => "1013"
                        "paginaFinal" => "1018"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24287022"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21742049/0000003300000011/v1_201412120159/S2174204914002736/v1_201412120159/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9913"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Recommended article of the month"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21742049/0000003300000011/v1_201412120159/S2174204914002736/v1_201412120159/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002736?idApp=UINPBA00004E"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Recommended article of the Month
Comment on “Percutaneous coronary intervention with everolimus-eluting bioabsorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry”
Comentário a «Intervenção coronária percutânea com próteses vasculares bioabsorvíveis eluidoras de everolimus na prática clínica de rotina: resultados precoces e a médio prazo do Registo Europeu Multicêntrico GOST-EU»
Henrique Cyrne Carvalho
Membro do Corpo Redatorial da Revista, Portuguesa de Cardiologia
Read
5018
Times
was read the article
1719
Total PDF
3299
Total HTML
Share statistics
 array:23 [
  "pii" => "S2174204914002736"
  "issn" => "21742049"
  "doi" => "10.1016/j.repce.2014.09.007"
  "estado" => "S300"
  "fechaPublicacion" => "2014-11-01"
  "aid" => "535"
  "copyright" => "Sociedade Portuguesa de Cardiologia"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "prv"
  "cita" => "Rev Port Cardiol. 2014;33:751-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2676
    "formatos" => array:3 [
      "EPUB" => 134
      "HTML" => 1897
      "PDF" => 645
    ]
  ]
  "Traduccion" => array:1 [
    "pt" => array:19 [
      "pii" => "S0870255114002339"
      "issn" => "08702551"
      "doi" => "10.1016/j.repc.2014.09.005"
      "estado" => "S300"
      "fechaPublicacion" => "2014-11-01"
      "aid" => "535"
      "copyright" => "Sociedade Portuguesa de Cardiologia"
      "documento" => "simple-article"
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "prv"
      "cita" => "Rev Port Cardiol. 2014;33:751-2"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2795
        "formatos" => array:3 [
          "EPUB" => 181
          "HTML" => 1909
          "PDF" => 705
        ]
      ]
      "pt" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Artigo recomendado do m&#234;s</span>"
        "titulo" => "Coment&#225;rio a &#171;Interven&#231;&#227;o coron&#225;ria percut&#226;nea com pr&#243;teses vasculares bioabsorv&#237;veis eluidoras de <span class="elsevierStyleItalic">everolimus</span> na pr&#225;tica cl&#237;nica de rotina&#58; resultados precoces e a m&#233;dio prazo do Registo Europeu Multic&#234;ntrico GOST&#8208;EU&#187;"
        "tienePdf" => "pt"
        "tieneTextoCompleto" => "pt"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "751"
            "paginaFinal" => "752"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Comment on &#8220;Percutaneous coronary intervention with everolimus&#8208;eluting bioabsorbable vascular scaffolds in routine clinical practice&#58; early and midterm outcomes from the European multicentre GHOST&#8208;EU registry&#8221;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "pt" => true
        ]
        "contienePdf" => array:1 [
          "pt" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Henrique Cyrne Carvalho"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Henrique"
                "apellidos" => "Cyrne Carvalho"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "pt"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2174204914002736"
          "doi" => "10.1016/j.repce.2014.09.007"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002736?idApp=UINPBA00004E"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114002339?idApp=UINPBA00004E"
      "url" => "/08702551/0000003300000011/v1_201411200056/S0870255114002339/v1_201411200056/pt/main.assets"
    ]
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2174204914002724"
    "issn" => "21742049"
    "doi" => "10.1016/j.repce.2014.05.009"
    "estado" => "S300"
    "fechaPublicacion" => "2014-11-01"
    "aid" => "549"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "article"
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Rev Port Cardiol. 2014;33:747-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2340
      "formatos" => array:3 [
        "EPUB" => 157
        "HTML" => 1675
        "PDF" => 508
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Image in Cardiology</span>"
      "titulo" => "Collateral damage from a coronary blush"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "747"
          "paginaFinal" => "749"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Danos colaterais com <span class="elsevierStyleItalic">blush</span> coron&#225;rio"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 3480
              "Ancho" => 2334
              "Tamanyo" => 688212
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;a&#8211;c&#41; Three-dimensional volume rendered cardiac computed tomography images showing the relationship of the coronary artery fistula &#40;arrow&#41; to the right ventricular outflow tract&#44; aorta and main pulmonary artery in anterior &#40;a&#41;&#44; anterolateral &#40;b&#41; and lateral &#40;c&#41; planes&#59; &#40;d&#41; curved multiplanar reformatted cardiac computed tomographic image showing the course of the coronary artery fistula anterior to the right ventricular outflow tract&#59; &#40;e&#41; multiplanar reformatted cardiac computed tomographic image showing the presence of a non-calcified bicuspid aortic valve&#59; &#40;f&#41; curved multiplanar reformatted cardiac computed tomographic image showing the presence of a concomitant aortopathy&#46; Ao&#58; aorta&#59; LAD&#58; left anterior descending coronary artery&#59; LV&#58; left ventricle&#59; MPA&#58; main pulmonary artery&#59; RVOT&#58; right ventricular outflow tract&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Panagiotis Koudounis, Jessica Webb, Camila Cabral, Natali Chung, Ronak Rajani"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Panagiotis"
              "apellidos" => "Koudounis"
            ]
            1 => array:2 [
              "nombre" => "Jessica"
              "apellidos" => "Webb"
            ]
            2 => array:2 [
              "nombre" => "Camila"
              "apellidos" => "Cabral"
            ]
            3 => array:2 [
              "nombre" => "Natali"
              "apellidos" => "Chung"
            ]
            4 => array:2 [
              "nombre" => "Ronak"
              "apellidos" => "Rajani"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0870255114002649"
        "doi" => "10.1016/j.repc.2014.05.007"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255114002649?idApp=UINPBA00004E"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002724?idApp=UINPBA00004E"
    "url" => "/21742049/0000003300000011/v1_201412120159/S2174204914002724/v1_201412120159/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Recommended article of the Month</span>"
    "titulo" => "Comment on &#8220;Percutaneous coronary intervention with everolimus-eluting bioabsorbable vascular scaffolds in routine clinical practice&#58; early and midterm outcomes from the European multicentre GHOST-EU registry&#8221;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "751"
        "paginaFinal" => "752"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Henrique Cyrne Carvalho"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "Henrique"
            "apellidos" => "Cyrne Carvalho"
            "email" => array:1 [
              0 => "henriquecyrnecarvalho&#64;hotmail&#46;com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Membro do Corpo Redatorial da Revista&#44; Portuguesa de Cardiologia"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Coment&#225;rio a &#171;Interven&#231;&#227;o coron&#225;ria percut&#226;nea com pr&#243;teses vasculares bioabsorv&#237;veis eluidoras de <span class="elsevierStyleItalic">everolimus</span> na pr&#225;tica cl&#237;nica de rotina&#58; resultados precoces e a m&#233;dio prazo do Registo Europeu Multic&#234;ntrico GOST-EU&#187;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="tb0005"></elsevierMultimedia></p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Abstract</span><p id="par0015" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Aims&#58;</span> Clinical data on the early and midterm outcomes of bioresorbable vascular scaffolds &#40;BVS&#41; in routine clinical practice are limited&#46; To fill this gap&#44; we report on the early and midterm clinical outcomes of PCI with everolimus-eluting BVS from the large multicentre GHOST-EU registry&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Methods and results&#58;</span> Between November 2011 and January 2014&#44; 1&#44;189 patients underwent percutaneous coronary intervention with one or more BVS &#40;Absorb BVS&#59; Abbott Vascular&#44; Santa Clara&#44; CA&#44; USA&#41; at 10 European centres&#46; The primary outcome of interest was target lesion failure &#40;TLF&#41;&#44; defined as the combination of cardiac death&#44; target vessel myocardial infarction&#44; or clinically driven target lesion revascularisation &#40;TLR&#41;&#46; A total of 1&#44;731 Absorb BVS were implanted at a mean of 12&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;4 atm&#46; Technical success was achieved in 99&#46;7&#37; of cases&#46; TLF was recorded in 67 of 1&#44;189 patients at a median of 109 &#40;interquartile range 8-227&#41; days after implantation&#46; The cumulative incidence of TLF was 2&#46;2&#37; at 30 days and 4&#46;4&#37; at six months&#46; The annualised rate of TLF was 10&#46;1&#37;&#46; At six months&#44; the rate of cardiac death was 1&#46;0&#37;&#44; target vessel myocardial infarction was 2&#46;0&#37;&#44; TLR was 2&#46;5&#37;&#44; and target vessel revascularisation was 4&#46;0&#37;&#46; Diabetes mellitus was the only independent predictor of TLF &#40;hazard ratio 2&#46;41&#44; 95&#37; confidence interval&#58; 1&#46;28-4&#46;53&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;006&#41;&#46; The cumulative incidence of definite&#47;probable scaffold thrombosis was 1&#46;5&#37; at 30 days and 2&#46;1&#37; at six months&#44; with 16 of 23 cases occurring within 30 days&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Conclusions&#58;</span> &#8220;Real-world&#8221; outcomes of BVS showed acceptable rates of TLF at six months&#44; although the rates of early and midterm scaffold thrombosis&#44; mostly clustered within 30 days&#44; were not negligible&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Comment</span><p id="par0020" class="elsevierStylePara elsevierViewall">A r&#225;pida evolu&#231;&#227;o relativa &#224; interven&#231;&#227;o coron&#225;ria percut&#226;nea processou-se de acordo com inova&#231;&#245;es que progressivamente vieram a garantir maior efic&#225;cia e&#44; indiscutivelmente&#44; maior seguran&#231;a&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Ap&#243;s a angioplastia por bal&#227;o&#44; primeira grande revolu&#231;&#227;o e evolu&#231;&#227;o no tratamento da doen&#231;a card&#237;aca isqu&#233;mica&#44; houve necessidade de encontrar solu&#231;&#227;o para o tratamento r&#225;pido e eficaz da disse&#231;&#227;o condicionante do fluxo que resultava do barotrauma induzido pelo bal&#227;o&#46; Nesse contexto surgem os <span class="elsevierStyleItalic">stents</span> autoexpans&#237;veis e&#44; posteriormente&#44; os <span class="elsevierStyleItalic">stents</span> expans&#237;veis por bal&#227;o&#46; Esta foi a segunda grande revolu&#231;&#227;o na cardiologia de interven&#231;&#227;o para o tratamento da doen&#231;a coron&#225;ria&#46; Al&#233;m de resolverem as condi&#231;&#245;es de interrup&#231;&#227;o aguda do fluxo j&#225; referidas&#44; estas pr&#243;teses mostram diminuir o processo de reestenose quando comparada com a angioplastia por bal&#227;o&#46; Este facto permitiu que les&#245;es de complexidade anat&#243;mica crescente fossem tratadas&#44; resultando deste facto um novo acr&#233;scimo cumulativo do processo de reestenose&#46; Era por isso necess&#225;rio encontrar solu&#231;&#245;es que procurassem resolver este problema de import&#226;ncia crescente&#44; determinado pelo enorme n&#250;mero de les&#245;es que passaram a ser tratadas em cada doente&#46; &#201; neste ambiente que surgem os <span class="elsevierStyleItalic">stents</span> met&#225;licos eluidores de subst&#226;ncias antiproliferativas&#44; que tinham como objetivo controlar o processo proliferativo que determinava o fen&#243;meno de reestenose&#46; Estes <span class="elsevierStyleItalic">stents</span>&#44; constitu&#237;dos por tr&#234;s elementos &#8211; plataforma met&#225;lica&#44; pol&#237;mero&#44; onde s&#227;o elu&#237;dos os f&#225;rmacos antiproliferativos&#44; e f&#225;rmaco antiproliferativo &#8211; constitu&#237;ram a terceira grande revolu&#231;&#227;o na cardiologia de interven&#231;&#227;o no tratamento da doen&#231;a card&#237;aca isqu&#233;mica&#46; Era a partir desse momento poss&#237;vel tratar maior n&#250;mero de doentes com grande efic&#225;cia&#44; permitindo que muitos dos doentes anteriormente candidatos a cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica pudessem ser tratados de forma adequada por interven&#231;&#227;o percut&#226;nea&#46; No entanto&#44; a efic&#225;cia associada &#224; antiprolifera&#231;&#227;o determinava tempos de reendoteliza&#231;&#227;o mais prolongados&#44; o que por si condicionava a necessidade de uma terap&#234;utica antiagregante tamb&#233;m mais prolongada para evitar o processo de trombose dependente do tempo mais longo da exposi&#231;&#227;o da malha met&#225;lica &#224; corrente sangu&#237;nea&#46; O pr&#243;prio pol&#237;mero&#44; necess&#225;rio &#224; elui&#231;&#227;o do f&#225;rmaco antiproliferativo&#44; tamb&#233;m se viria a demonstrar estar associado ao processo inflamat&#243;rio que conduzia ao atraso na reendoteliza&#231;&#227;o do <span class="elsevierStyleItalic">stent</span>&#46; O passo seguinte foi o de utilizar pol&#237;meros bioabsorv&#237;veis que diminu&#237;ssem o processo a que anteriormente nos referimos&#46; No entanto&#44; persistia um problema&#58; estavam a ser implantadas pr&#243;teses definitivas para tratar um processo que por si s&#243; era tempor&#225;rio&#44; determinando condi&#231;&#245;es fisiopatol&#243;gicas que condicionavam novos processos e novas &#171;doen&#231;as&#187;&#58; os processos de reestenose e de trombose da pr&#243;tese intracoron&#225;ria&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">&#201; neste ambiente que surge a quarta revolu&#231;&#227;o no tratamento da doen&#231;a card&#237;aca isqu&#233;mica por via percut&#226;nea&#58; o desenvolvimento de pr&#243;teses intracoron&#225;rias eluidoras de f&#225;rmacos com pol&#237;mero e plataforma completamente bioabsorv&#237;veis<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Da informa&#231;&#227;o cient&#237;fica j&#225; dispon&#237;vel relativamente a estas pr&#243;teses e&#44; particularmente a da ABBOTT VASCULAR &#40;ABSORB BVS&#44; constitu&#237;da por um pol&#237;mero bioabsorv&#237;vel&#41; que &#233; a que j&#225; apresenta mais evid&#234;ncia cient&#237;fica&#44; ressaltam dois elementos base&#58; s&#227;o pr&#243;teses eficazes e associadas a baixa taxa de complica&#231;&#245;es tromb&#243;ticas&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Ap&#243;s uma primeira fase em que foram testadas no modelo animal com enorme sucesso&#44; passou-se para a sua utiliza&#231;&#227;o em humanos&#44; com les&#245;es de baixa complexidade anat&#243;mica&#46; Est&#227;o neste momento a decorrer estudos de larga escala&#44; procurando encontrar esses mesmos resultados na popula&#231;&#227;o em geral e em subgrupos de doentes associados a perfis de maior complexidade anat&#243;mica e cl&#237;nica&#46; At&#233; este ponto&#44; esses resultados t&#234;m sido encorajadores&#46; O conceito de que estas pr&#243;teses n&#227;o sirvam apenas como um elemento de conten&#231;&#227;o da placa &#8211; <span class="elsevierStyleItalic">scaffolding</span> &#8211;&#44; mas possam tamb&#233;m ser um elemento de regenera&#231;&#227;o funcional da placa e da fisiologia normal do segmento arterial coron&#225;rio&#44; est&#225; progressivamente a ganhar consist&#234;ncia&#46; Por outro lado&#44; tem sido observado em estudos morfol&#243;gicos intracoron&#225;rios&#44; que a cicatriza&#231;&#227;o ap&#243;s absor&#231;&#227;o completa da pr&#243;tese se fa&#231;a&#44; ao contr&#225;rio do que acontece com os <span class="elsevierStyleItalic">stents</span> met&#225;licos&#44; com alargamento luminal e alargamento da &#225;rea do segmento tratado<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#8211;5</span></a>&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">O Registo em an&#225;lise procura a informa&#231;&#227;o relativa &#224; utiliza&#231;&#227;o destas pr&#243;teses tempor&#225;rias em condi&#231;&#245;es de tratamento de doentes do &#171;mundo real&#187;&#44; em ambiente diferente do utilizado nos estudos que permitiram a sua certifica&#231;&#227;o&#46; Dos resultados desta avalia&#231;&#227;o que envolveu mais de 1000 doentes&#44; o maior registo publicado sobre estas pr&#243;teses&#44; destacam-se duas conclus&#245;es essenciais&#58; o BVS apresenta taxas aceit&#225;veis de TLF aos seis meses e taxas n&#227;o desprez&#237;veis de trombose&#44; que ocorre sobretudo nos primeiros 30 dias&#44; e se aproximam das identificadas nos DES de primeira gera&#231;&#227;o&#46; Apesar de n&#227;o serem n&#250;meros alarmantes&#44; n&#227;o s&#227;o negligenci&#225;veis e podem justificar algum cuidado na utiliza&#231;&#227;o de BVS em popula&#231;&#245;es n&#227;o selecionadas&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Este registo identifica tamb&#233;m os fatores preditivos de <span class="elsevierStyleItalic">target lesion failure</span> &#40;TLF&#41; e investiga o impacto da curva de aprendizagem no resultado cl&#237;nico&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Ser&#225; interessante avaliar o comportamento desta popula&#231;&#227;o ao fim de tempos de <span class="elsevierStyleItalic">follow-up</span> mais prolongados&#46; Teremos que aguardar por esses resultados e continuar a ser criteriosos na sele&#231;&#227;o dos doentes e exigentes tecnicamente na sua utiliza&#231;&#227;o&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:3 [
        0 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Abstract"
        ]
        1 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Comment"
        ]
        2 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:5 [
        "identificador" => "tb0005"
        "tipo" => "MULTIMEDIATEXTO"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "texto" => array:1 [
          "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0010" class="elsevierStylePara elsevierViewall">Percutaneous coronary intervention with everolimus-eluting bioabsorbable vascular scaffolds in routine clinical practice&#58; early and midterm outcomes from the European multicentre GHOST-EU registry&#46; Davide Capodanno&#44; Tommaso Gori&#44; Holger Nef&#44; Azeem Latib&#44; Julinda Mehilli&#44; Maciej Lesiak&#44; Giuseppe Caramanno&#44; Christoph Naber&#44; Carlo Di Mario&#44; Antonio Colombo&#44; Piera Capranzano&#44; Jens Wiebe&#44; Aleksander Araszkiewicz&#44; Salvatore Geraci&#44; Stelios Pyxaras&#44; Alessio Mattesini&#44; Toru Naganuma&#44; Thomas M&#252;nzel&#44; Corrado Tamburino&#46; EuroIntervention 2014&#59;10-online publish-ahead-of-print July 2014&#46; doi&#58; 10&#46;4244&#47;EIJY14M07&#95;11</p></span>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system&#58; multimodality imaging assessment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "H&#46;M&#46; Garc&#237;a-Garc&#237;a"
                            1 => "C&#46; Schultz"
                            2 => "E&#46; Duckers"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4244/EIJV8I10A175"
                      "Revista" => array:6 [
                        "tituloSerie" => "EuroIntervention&#46;"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "1126"
                        "paginaFinal" => "1127"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23425538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46; Diletti"
                            1 => "V&#46; Farooq"
                            2 => "C&#46; Girasis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Late lumen enlargement&#58; does bioresorption matter with small vessel size&#63; Insight from the ABSORB cohort B trial&#46; Heart&#46;"
                        "fecha" => "2013"
                        "volumen" => "99"
                        "paginaInicial" => "98"
                        "paginaFinal" => "105"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "ABSORB II randomized controlled trial&#58; a clinical evaluation to compare the safety&#44; efficacy&#44; and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions&#58; rationale and study design"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46; Diletti"
                            1 => "P&#46;W&#46; Serruys"
                            2 => "V&#46; Farooq"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ahj.2012.08.010"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am Heart J&#46;"
                        "fecha" => "2012"
                        "volumen" => "164"
                        "paginaInicial" => "654"
                        "paginaFinal" => "663"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23137495"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "ABSORB-EXTEND Investigators&#46; Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold&#46; an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46; Muramatsu"
                            1 => "Y&#46; Onuma"
                            2 => "H&#46;M&#46; Garc&#237;a-Garc&#237;a"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcin.2012.10.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "JACC Cardiovasc Interv&#46;"
                        "fecha" => "2013"
                        "volumen" => "6"
                        "paginaInicial" => "247"
                        "paginaFinal" => "257"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23517836"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Posi&#231;&#227;o sobre suportes vasculares restaurativos transit&#243;rios coron&#225;rios em Portugal"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46; Campante Teles"
                            1 => "H&#46; Pereira"
                            2 => "H&#46; Cyrne de Carvalho"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.repc.2013.05.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Port Cardiol&#46;"
                        "fecha" => "2013"
                        "volumen" => "32"
                        "paginaInicial" => "1013"
                        "paginaFinal" => "1018"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24287022"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21742049/0000003300000011/v1_201412120159/S2174204914002736/v1_201412120159/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9913"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Recommended article of the month"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21742049/0000003300000011/v1_201412120159/S2174204914002736/v1_201412120159/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204914002736?idApp=UINPBA00004E"
]
Article information
ISSN: 21742049
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 5 8 13
2024 October 29 31 60
2024 September 34 22 56
2024 August 32 23 55
2024 July 23 29 52
2024 June 19 18 37
2024 May 22 20 42
2024 April 22 22 44
2024 March 21 18 39
2024 February 33 23 56
2024 January 25 22 47
2023 December 14 25 39
2023 November 26 23 49
2023 October 16 18 34
2023 September 17 21 38
2023 August 22 18 40
2023 July 17 5 22
2023 June 16 11 27
2023 May 29 29 58
2023 April 8 5 13
2023 March 18 20 38
2023 February 19 20 39
2023 January 34 13 47
2022 December 22 21 43
2022 November 32 23 55
2022 October 22 12 34
2022 September 19 25 44
2022 August 24 27 51
2022 July 32 34 66
2022 June 17 17 34
2022 May 14 31 45
2022 April 25 22 47
2022 March 15 21 36
2022 February 18 26 44
2022 January 21 28 49
2021 December 14 30 44
2021 November 30 27 57
2021 October 23 37 60
2021 September 10 34 44
2021 August 25 28 53
2021 July 13 27 40
2021 June 27 12 39
2021 May 27 23 50
2021 April 23 29 52
2021 March 29 7 36
2021 February 44 12 56
2021 January 20 9 29
2020 December 46 11 57
2020 November 19 10 29
2020 October 15 2 17
2020 September 53 6 59
2020 August 13 7 20
2020 July 51 3 54
2020 June 35 11 46
2020 May 28 5 33
2020 April 46 6 52
2020 March 42 5 47
2020 February 40 17 57
2020 January 36 9 45
2019 December 19 4 23
2019 November 37 5 42
2019 October 44 7 51
2019 September 7 5 12
2019 August 35 11 46
2019 July 34 11 45
2019 June 16 7 23
2019 May 44 4 48
2019 April 21 16 37
2019 March 50 6 56
2019 February 53 10 63
2019 January 42 6 48
2018 December 28 12 40
2018 November 28 5 33
2018 October 57 26 83
2018 September 29 11 40
2018 August 25 5 30
2018 July 14 2 16
2018 June 29 3 32
2018 May 35 5 40
2018 April 37 6 43
2018 March 53 8 61
2018 February 31 6 37
2018 January 26 4 30
2017 December 46 6 52
2017 November 27 8 35
2017 October 42 12 54
2017 September 33 7 40
2017 August 37 14 51
2017 July 29 10 39
2017 June 33 14 47
2017 May 37 8 45
2017 April 21 3 24
2017 March 30 42 72
2017 February 24 7 31
2017 January 27 1 28
2016 December 29 11 40
2016 November 16 5 21
2016 October 12 10 22
2016 September 23 5 28
2016 August 5 1 6
2016 July 8 3 11
2016 June 15 3 18
2016 May 16 3 19
2016 April 22 25 47
2016 March 35 19 54
2016 February 31 37 68
2016 January 32 20 52
2015 December 59 21 80
2015 November 27 19 46
2015 October 34 14 48
2015 September 45 17 62
2015 August 32 11 43
2015 July 22 10 32
2015 June 15 0 15
2015 May 26 9 35
2015 April 31 13 44
2015 March 16 7 23
2015 February 30 12 42
2015 January 43 19 62
2014 December 24 10 34
Show all

Follow this link to access the full text of the article

Idiomas
Revista Portuguesa de Cardiologia (English edition)
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.